Latest filing published 01 Oct 2013 for OptimizeRx Corp.
No signal scores available.
Shadron L. Stastney discloses dealings in 2 companies, chiefly Omnireliant Holdings, Inc. and OptimizeRx Corp. Over a trading history stretching from 16 July 2013 to 20 September 2013, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 1 October 2013 with a share grant in OptimizeRx Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations